Published 2010
Table of Contents:
“…Contents:
Melanoma -- BRAF and RAS mutated in approximately 70% of cases -- Mouse models of
melanoma -- Oncogenic BRAF can be a founder mutation in
melanoma -- Mouse models replicate human disease -- BRAF inhibitors induce paradoxical activation of CRAF and drive pathway activation -- Kinase-dead BRAF mimics this and potentiates RAS ooncogenesis -- BRAF inhibitors induce excellent responses in patients, but may induce mechanism-based side effects through CRAF.…”
Call Number:
Loading…
Located:
Loading…
Get full text
Series
Electronic
Video